FDA Approves Keytruda as First Cancer Treatment Based on a Genetic Biomarker

FDA Approves Keytruda as First Cancer Treatment Based on a Genetic Biomarker


The U.S. Food and Drug Administration recently approved Keytruda for treatment of patients whose cancers have a specific genetic feature . The FDA has traditionally approved cancer treatments based on where in the body the cancer started - for example, the lung or breast.



from Biotech News